Factor V Leiden: A Clinical Review
- 1 August 2001
- journal article
- review article
- Published by Elsevier in The Lancet Healthy Longevity
- Vol. 322 (2) , 88-102
- https://doi.org/10.1097/00000441-200108000-00007
Abstract
No abstract availableKeywords
This publication has 173 references indexed in Scilit:
- The Factor V Leiden Mutation Is Not a Common Cause of Pregnancy-Induced Hypertension in JapanSeminars in Thrombosis and Hemostasis, 1999
- The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin MutationNew England Journal of Medicine, 1999
- APC-Resistenz und venöse Thrombophilie: Molekulargenetische Prävalenzstudie in der deutschen BevölkerungDeutsche Medizinische Wochenschrift (1946), 1999
- Laboratory Diagnosis of Hereditary ThrombophiliaSeminars in Thrombosis and Hemostasis, 1998
- The factor V Leiden mutation may predispose women to severe preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1996
- The G1691A mutation of the coagulation factor V gene (factor V Leiden) is rare in Chinese: an analysis of 618 individualsHuman Genetics, 1996
- Mutant factor V (Arg506Gln) in healthy centenariansThe Lancet, 1996
- Risk of idiopathic cardiovascular death and rionfatal venous thromboembolism in women using oral contraceptives with differing progestagen componentsThe Lancet, 1995
- Placental pathologic features of preterm preeclampsiaAmerican Journal of Obstetrics and Gynecology, 1995
- PULMONARY EMBOLISMThe Lancet, 1961